Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031622
Filing Date
2024-08-13
Accepted
2024-08-13 16:15:39
Documents
53
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 614894
2 ex31-1.htm EX-31.1 11901
3 ex31-2.htm EX-31.2 11909
4 ex32-1.htm EX-32.1 10618
5 form10-q_001.jpg GRAPHIC 93784
  Complete submission text file 0001493152-24-031622.txt   3916672

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pcsa-20240630.xsd EX-101.SCH 35771
7 XBRL CALCULATION FILE pcsa-20240630_cal.xml EX-101.CAL 37971
8 XBRL DEFINITION FILE pcsa-20240630_def.xml EX-101.DEF 144153
9 XBRL LABEL FILE pcsa-20240630_lab.xml EX-101.LAB 325045
10 XBRL PRESENTATION FILE pcsa-20240630_pre.xml EX-101.PRE 246969
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 393555
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39531 | Film No.: 241201682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)